Gordon Y B, Ratky S M, Baker L R, Letchworth A T, Leighton P C, Chard T
Br J Obstet Gynaecol. 1976 Apr;83(4):287-91. doi: 10.1111/j.1471-0528.1976.tb00828.x.
Levels of fibrin/fibrinogen degradation products have been measured by a sensitive and specific radioimmunoassay in pregnancies associated with pre-eclampsia or essential hypertension. The incidence of elevated levels was low (2-4%) in mild and moderate cases, and rather higher (30%) in severe cases. In no patients were the levels consistently elevated prior to the onset of clinical signs.